US Approvals Analysis: FDA Makes Efficiency Mark For PMAs
Executive Summary
The US agency achieved its most efficient performance in the past 15 years for original PMA submission reviews in the most recently completed application cohort. PMA approval volumes also remain healthy. Meanwhile, 510(k) review times have leveled off and clearance volumes have dropped slightly.
You may also be interested in...
MDUFA IV Takes Shape: A Catalogue Of Draft Commitments
More specific details have emerged about the agreement "in principle" announced last week by FDA and industry negotiators on the next round of the medical device user-fee program, which will extend from fiscal years 2018 through 2022.
FDA Approves Edwards' Rapid-Deployment Minimally Invasive Surgical Valve
The system combines the company's proven tissue surgical valve platform with technology developed for transcatheter valves.
US Approvals Analysis: July A Good Month For PMAs; 510(k)s Down In 2016
A look at Medtech Insight's Approval Tracker data shows that last month was a relatively active one for US FDA approvals of novel devices via the PMA, panel-track supplement and de novo routes. But 510(k) clearance totals are down so far in 2016 compared to recent years.